| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) | 
|---|
| 07/02/2009 | US20090169476 Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer  | 
| 07/02/2009 | CA2709635A1 Polypeptide-nucleic acid conjugates and uses thereof  | 
| 07/02/2009 | CA2708626A1 Recovery of hydrophobic peptides from oils  | 
| 07/01/2009 | EP2074142A1 Compounds for stimulating p-glycoprotein function and uses thereof  | 
| 07/01/2009 | EP2074138A1 Neuroprotective peptide inhibitors of ap-1 signaling and uses therefor  | 
| 07/01/2009 | EP2074137A1 Compounds as aptamer-dimers and their uses in diagnosis and therapy  | 
| 07/01/2009 | EP2074134A1 Method for peptide synthesis  | 
| 07/01/2009 | EP2073829A2 Stabilized therapeutic small helical antiviral peptides  | 
| 07/01/2009 | EP1951747B1 Process and intermediates for the synthesis of caspofungin  | 
| 07/01/2009 | EP1713439B1 Pharmaceutical preparation for the oral cavity  | 
| 07/01/2009 | EP1673633B1 Method for detecting feline immunodeficiency virus  | 
| 07/01/2009 | EP1583564B1 Improved linkers for radiopharmaceutical compounds  | 
| 07/01/2009 | EP1301486B1 Imidazolidinones as ns3-serine protease inhibitors of hepatitis c virus  | 
| 07/01/2009 | EP1124846B1 Nucleotide and protein sequences of nogo genes and methods based thereon  | 
| 07/01/2009 | CN101469016A Trichosanthin protein derived peptide and use thereof  | 
| 07/01/2009 | CN100507563C N.epsilon. and/or n.alpha. derivatized, metal and organic protected l-histidine for coupling to biomolecules for highly efficient labeling with [m(oh2)3(co)3]+ by fac coordination  | 
| 07/01/2009 | CN100506981C Protein hydrolysates enriched in peptides having a carboxy terminal proline residue  | 
| 06/30/2009 | US7553962 Cross-linked glycopeptide-cephalosporin antibiotics  | 
| 06/30/2009 | US7553929 Administering nuclear factor kappa beta (nf-kb)peptide nuclear localization sequence to inhibit import of stress-responsive transcription factor; septic shock, skin disorders, autoimmune diseases  | 
| 06/30/2009 | CA2161445C Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines  | 
| 06/30/2009 | CA2108119C Glial mitogenic factors, their preparation and use  | 
| 06/25/2009 | WO2009079053A2 High affinity metal-oxide binding peptides with reversible binding  | 
| 06/25/2009 | WO2009078977A2 Compositions and methods to concurrently treat or prevent multiple diseases with cupredoxins  | 
| 06/25/2009 | WO2009078820A1 Cationic core-shell peptide nanoparticles  | 
| 06/25/2009 | WO2009077401A1 Antitumoral compounds  | 
| 06/25/2009 | WO2009076966A2 Rhoc-based immunotherapy  | 
| 06/25/2009 | WO2009010733A3 Peptide gap junction modulators  | 
| 06/25/2009 | US20090163844 Methods for the treatment or prevention of scars and/or keloids  | 
| 06/25/2009 | US20090163695 Process for the preparation of bicyclic peptide compounds  | 
| 06/25/2009 | US20090163426 Prostate specific antigen; immobilization; antiproliferative agents; drug delivery; contain cleavage sites specifically cleaved by prostate specific membrane antigen (PSMA); useful for substantially inhibiting the non-specific toxicity of a variety of therapeutic drugs  | 
| 06/25/2009 | US20090163425 Peptide Inhibiting Angiotensin Converting Enzyme  | 
| 06/25/2009 | US20090163423 Exendins and Exendin Agonist Analogs to Regulate Gastrointestinal Motility  | 
| 06/25/2009 | US20090163413 Dental products comprising bone growth enhancing peptide  | 
| 06/25/2009 | US20090163410 Novel Peptides and the Biological Use Thereof  | 
| 06/25/2009 | US20090163405 Angiogenic peptides and uses thereof  | 
| 06/25/2009 | US20090162875 Peptide diagnostic agent for lyme disease  | 
| 06/25/2009 | US20090162845 Affinity tag nucleic acid and protein compositions, and processes for using same  | 
| 06/25/2009 | US20090162844 Identification and characterization of racemases, definition of protein signatures, and a test for detecting D-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase  | 
| 06/25/2009 | US20090162437 Modified self-assembling peptides  | 
| 06/25/2009 | US20090162375 Resistin antagonists and their use  | 
| 06/25/2009 | US20090162336 Novel Tools for the Diagnosis and Treatment of Alzheimer's Disease  | 
| 06/25/2009 | US20090162332 Methods and compositions for treating brain diseases  | 
| 06/25/2009 | US20090162296 Approach to treat intraocular hypertension  | 
| 06/25/2009 | CA2710061A1 Rhoc-based immunotherapy  | 
| 06/25/2009 | CA2708080A1 Antitumoral compounds  | 
| 06/24/2009 | EP2072045A2 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease  | 
| 06/24/2009 | EP1513869B1 Polynucleotides for the detection and quantification of hepatitis b virus nucleic acids  | 
| 06/24/2009 | CN101466729A Lysobactin amides  | 
| 06/24/2009 | CN100503634C T4 synthetic product and application thereof  | 
| 06/23/2009 | US7550560 Deprotecting amino acid linked to solid phase resin by admixing with solution in transparent vessel while irradiating with microwaves, coupling/activating/hybridizing amino acids, then cleaving  | 
| 06/23/2009 | US7550558 Antimicrobial peptides and methods for identifying and using such peptides  | 
| 06/23/2009 | US7550430 Bactericides; immobilized  | 
| 06/23/2009 | US7550428 treating fungal infections; improved thermal stability and water solubility; releasing carbohydrate upon dispersion of the complex in water  | 
| 06/23/2009 | US7550425 Diuretic peptide conjugates  | 
| 06/23/2009 | CA2139100C New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents  | 
| 06/18/2009 | WO2009076672A1 Advantageous salts of mu-opiate receptor peptides  | 
| 06/18/2009 | WO2009074628A1 Polypeptides, cyclic polypeptides and pharmaceutical comprising thereof for non invasive specific imaging of fibrosis  | 
| 06/18/2009 | WO2009074569A1 Targeting and therapeutic compounds with a polyproline-comprising spacer and gas-filled microvesicles comprising said compounds  | 
| 06/18/2009 | WO2004039962A3 Methods for producing polypeptide-tagged collections and capture systems containing the tagged polypeptides  | 
| 06/18/2009 | WO2003089458A3 Conjugates of membrane translocating agents and pharmaceutically active agents  | 
| 06/18/2009 | US20090156785 Produced from Chromobacterium cultures; depsipeptides; immunosuppressants; for treatment of graft-versus-host disease  | 
| 06/18/2009 | US20090156508 Synthetic peptide amides and dimeric forms thereof  | 
| 06/18/2009 | US20090156505 Self-assembly and mineralization of peptide-amphiphile nanofibers  | 
| 06/18/2009 | US20090156499 Antimicrobial Peptides and Methods of Identifying the Same  | 
| 06/18/2009 | US20090156490 Peptides for diagnostic and therapeutic methods for celiac sprue  | 
| 06/18/2009 | US20090156472 Cyclic Depsipeptides  | 
| 06/18/2009 | US20090155843 Tnf antagonists  | 
| 06/18/2009 | US20090155335 Non-leaching non-fouling antimicrobial coatings  | 
| 06/18/2009 | US20090155310 Hn epitope recognized by avian immune system and antigenic variant newcastle disease viruses carrying changes in the epitope  | 
| 06/18/2009 | US20090155306 Pamps, pathogen associated molecular patterns  | 
| 06/18/2009 | US20090155304 Modified Cyanovirin-N Polypeptide  | 
| 06/18/2009 | US20090151600 Adhesive protein extracted from Mytilus galloprovincialis, Mytilus galloprovincialis foot protein-5; can be used as medical adhesives as they are non-toxic to the human body and do not impose immunogenicity; water-resistant bioadhesives  | 
| 06/18/2009 | CA2707733A1 Advantageous salts of mu-opiate receptor peptides  | 
| 06/17/2009 | EP2071335A2 Detection of auto-antibodies from patients suffering from rheumatoid arthritis  | 
| 06/17/2009 | EP2070944A1 Specific binding agents of human angiopoietin-2  | 
| 06/17/2009 | EP2069388A2 Peptides derived from the c2 domain of epsilon pkc, and use thereof  | 
| 06/17/2009 | EP2069308A2 Azonafide derived tumor and cancer targeting compounds  | 
| 06/17/2009 | EP1896386A4 Hyaluronic acid binding peptides enhance host defense against pathogenic bacteria  | 
| 06/17/2009 | EP1790654B1 Peptide capable of binding to insulin-binding protein and adsorbent  | 
| 06/17/2009 | EP1780215B1 Crohn's disease antibody epitope peptide and reagent for testing crohn's disease  | 
| 06/17/2009 | EP1735345B1 Processes for preparing eptifibatide and pertinent intermediate compounds  | 
| 06/17/2009 | EP1527341B1 Interfacial biomaterials  | 
| 06/17/2009 | EP1140131B1 Peptides and peptide analogues designed from hfe protein and their uses in the treatment of iron overload diseases  | 
| 06/17/2009 | CN101456902A Microorganism metabolites feed supplement cyclic decapeptide and application  | 
| 06/17/2009 | CN101456901A 12 peptide ZA for inhibiting hepatitis c virus to infect human cell and preparation method and application  | 
| 06/17/2009 | CN101456900A 12 peptide ZB for inhibiting hepatitis c virus to infect human cell and preparation method and application  | 
| 06/17/2009 | CN101456899A 12 peptide ZD for inhibiting hepatitis c virus to infect human cell and preparation method and application  | 
| 06/17/2009 | CN100500692C Novel LHRH antagonists, preparation method and pharmaceutical use thereof  | 
| 06/17/2009 | CN100500209C CLK-peptide and SLK-peptide  | 
| 06/16/2009 | US7547759 Stimulating cytotoxic T-lymphocytes  | 
| 06/16/2009 | US7547677 Peptide or fusion protein containing peptide binds to gut of sap-sucking insects, e.g., aphids; when bound, peptide inhibits binding of targeted virus to insect gut; when peptide is expressed in fluids of transgenic plants, is taken up by insect with sap, binds to gut receptors, inhibits transmission  | 
| 06/16/2009 | US7547439 Elicit immune response from human lymphocytes when complexed with a major histocompatibility complex molecule type HLA-A2; polypeptide  | 
| 06/16/2009 | CA2192786C Cyclopeptolide inhibitors of adhesion molecules  | 
| 06/11/2009 | WO2009073168A1 Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereof  | 
| 06/11/2009 | WO2009072610A1 Cancer vaccine composition  | 
| 06/11/2009 | WO2009072609A1 Gene capable of increasing the production of oil-and-fat in plant, and use thereof  | 
| 06/11/2009 | WO2009072608A1 Gene capable of increasing the production of oil-and-fat in plant, and use thereof  | 
| 06/11/2009 | WO2009072555A1 Cancer vaccine  | 
| 06/11/2009 | WO2009071486A1 Human cd154-binding synthetic peptide and uses thereof  | 
| 06/11/2009 | WO2009071276A2 Allele and isotope-specific intervention on mhc class ii molecules associated with autoimmune diseases by means of peptides  |